ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 40909459

Case Report: Neuroendocrine carcinoma of the breast: a review of the literature and illustration of six cases.

Albayrak NE. Front Med (Lausanne), 2025. Cited by 2 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Case Report: Neuroendocrine carcinoma of the breast: a review of the literature and illustration of six cases. Papers, record 40909459. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40909459

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Case Report: Neuroendocrine carcinoma of the breast: a review of the literature and illustration of six cases.
PubMed
Journal
Front Med (Lausanne)
PubMed
Year
2025
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-09-15
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Albayrak NENazire E

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126,659,223Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives.Oncologist2016https://conductscience.org/library/papers/26659223PubMed
230,476,894Somatostatin receptor SSTR2A and SSTR5 expression in neuroendocrine breast cancer.Ann Diagn Pathol2019https://conductscience.org/library/papers/30476894PubMed
323,658,459Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.Clin Cancer Res2013https://conductscience.org/library/papers/23658459PubMed
427,870,574
Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study.
J Clin Oncol2017https://conductscience.org/library/papers/27870574PubMed
532,951,906INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.Pathology2021https://conductscience.org/library/papers/32951906PubMed
623,000,897Comprehensive molecular portraits of human breast tumours.Nature2012https://conductscience.org/library/papers/23000897PubMed
728,884,749Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast.Mod Pathol2018https://conductscience.org/library/papers/28884749PubMed
833,584,543Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues.Front Endocrinol (Lausanne)2020https://conductscience.org/library/papers/33584543PubMed
924,851,054Primary small-cell neuroendocrine carcinoma of the male breast: a rare case report with review of the literature.Onco Targets Ther2014https://conductscience.org/library/papers/24851054PubMed
1033,375,317PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects.Int J Mol Sci2020https://conductscience.org/library/papers/33375317PubMed

1 to 10 of 33

See all 33 references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42,370,168Primary large cell neuroendocrine carcinoma of the breast with metastasis in the lymph nodes: a case report and literature review.Front Oncol2026https://conductscience.org/library/papers/42370168PubMed
42,327,776Adjuvant chemotherapy combined with pembrolizumab immunotherapy for primary triple-negative neuroendocrine carcinoma of the breast: a case report and literature review.Front Immunol2026https://conductscience.org/library/papers/42327776PubMed

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
FGFR12,260PubTator's text mininghttps://conductscience.org/library/genes/2260NCBI Gene
MTOR2,475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
PIK3CA5,290PubTator's text mininghttps://conductscience.org/library/genes/5290NCBI Gene
PIK3CB5,291PubTator's text mininghttps://conductscience.org/library/genes/5291NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40909459

GET https://conductscience.org/api/papers/v1/40909459/references?page=2

API referenceFor AI assistants